PaulMaurin

Associate

巴黎 + 33.1.56.59.39.13

聯絡

*Share

Paul Maurin's experience includes French and international venture capital, private equity, M&A, and capital markets.

Paul regularly advises listed and unlisted companies and their managers at every stage of their development as well as their investors (venture capital and private equity firms, institutional and industrial investors). He represents issuers and investors in financing rounds, private and public M&A, LBOs, IPOs, private placements, and tender offers.

Paul's recent experience includes technology and life sciences companies (Stratumn, Voluntis, Nanobiotix). His recent investor-side representations include Partech Partners, Bpifrance, Creadev (Mulliez family), Piton Capital LLP, and Alven Capital Partners.

Examples of Paul's representations include the acquisitions by Ansys of Optis; the sale of A2Mac1 by its founders; the financing rounds of Doctolib, ManoMano, and Tinubu Square; the IPOs of Voluntis and Tikehau; the private placements of Nanobiotix and Cellnovo; and the share capital increase of Voltalia.

執業經驗

  • CARMAT completes €10.3 million share capital increaseJones Day represented CARMAT SA, the designer and developer of the world's most advanced total artificial heart listed on Euronext Growth Paris, in connection with its €10.3 million share capital increase without preferential subscription rights but with a priority right through a public offering.
  • Amolyt Pharma acquired by AstraZenecaJones Day advised Amolyt Pharma, a global, clinical-stage biopharmaceutical company specializing in developing therapeutic peptides for rare endocrine and related diseases, in its $1.05 billion acquisition by AstraZeneca.
  • Silicon Mobility sold to IntelJones Day advised Silicon Mobility SAS in the acquisition of the company by Intel Corporation.
  • Arverne Group combines with Transition to publicly list on Euronext Paris the future French leader in geothermal and low-carbon lithium to drive energy transitionJones Day advised Arverne Group SAS, a French company ("Arverne"), in its business combination with Euronext listed Transition SA to create the future French leader in geothermal and low-carbon lithium production.
  • Deezer invests to create livestreaming powerhouse as Driift acquires DreamstageJones Day advised Deezer S.A. in its £4 million investment in the merger of Driift and Dreamstage, creating a livestreaming powerhouse.
  • Deezer merges with and into I2PO S.A.Jones Day advised Deezer S.A. in the context of the SPAC transaction whereby Deezer S.A. merged with and into I2PO S.A., a French SPAC listed on the professional segment of the regulated market of Euronext Paris and the related PIPE financing.
  • Bpifrance (Large Venture) participates in $355 million Series D financing round of ExotecJones Day represented Bpifrance (Large Venture) in the $355 million Series D round of financing of Exotec, a provider of robotic solutions for warehouses, led by Goldman Sachs Asset Management, along with Bpifrance (Large Venture) and 83North, becoming the first French industrial unicorn.
  • Amolyt Pharma raises $80 million in Series B financing roundJones Day advised Amolyt Pharma, a French based company engaged in the research and development of new therapeutic strategies for the treatment of rare endocrine and metabolic diseases, in connection with its $80 million Series B round of financing co-led by Sectoral Asset Management and Andera Partners.
  • Nanobiotix completes $113.3 million IPO on NasdaqJones Day represented Nanobiotix S.A., a French clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, in connection with its $113.3 million initial public offering in the United States and listing on Nasdaq.
  • Tinubu® Square acquires U.S. company eSURETY®Jones Day advised Tinubu® Square in its acquisition of U.S.-based eSURETY®, a cloud-based specialty software provider, enabling carriers, brokers, and MGAs to securely apply, quote, bond, issue, and support every form of surety as well as offering a powerful direct-to-the-consumer experience on any device from any browser, anywhere in the world.
  • Voltalia completes €376 million capital increase with shareholders’ preferential subscription rightsJones Day represented Voltalia S.A. in connection with its €376 million offering by way of preferential subscription rights allocated to Voltalia's existing shareholders in a public offering in France and internationally in private placements to institutional investors.
  • Gimv invests in Coolworld RentalsJones Day advised Gimv in its acquisition of a majority shareholding in fast-growing Coolworld Rentals, a full-service renter of cooling and heating equipment.
  • Bain Capital Ventures participates in $70 million Series C financing round of MiraklJones Day represented Bain Capital Ventures in connection with the $70 million Series C round of financing of Mirakl, a global leader in e-commerce marketplace platforms.
  • Findos Investor acquires worldwide business of Röder HTS Höcker GmbHJones Day advised funds managed by Findos Investor in connection with acquisition of the entire worldwide business operations of Röder HTS Höcker GmbH.
  • Athyrium Capital Management partially issues second tranche of bond issueJones Day advised Athyrium Capital Management, LP in connection with the partial issuance of the second tranche of its bond issue.
  • Bpifrance and Danone Manifesto Ventures participate in €25 million Series B financing round of AgricoolJones Day represented Bpifrance and Danone Manifesto Ventures, as lead investors, in connection with the €25 million (US$28.2 million) Series B financing round of Agricool, a greentech company developing and using containers to grow fruits and vegetables in urban areas.
  • Stilla Technologies raises €16 million in Series A roundJones Day represented Stilla Technologies SAS, the European provider of pioneering digital PCR solutions for high precision genetic analysis, in connection with its issuance of €16 million (US$18 million) of Series A Convertible Preferred Stock in a private placement to Illumina Ventures, Kurma Partners, LBO France, BNP Paribas Développement, Paris Saclay Seeds, and Idinvest Partners.
  • Deezer enters into exclusive distribution agreement with Rotana, leading media group in Middle EastJones Day is assisting Deezer, a leader in music streaming, in the negotiation and execution of an exclusive distribution agreement with Rotana Group, the leading media group in the Middle East, to distribute Rotana's audio and video content catalogue exclusively on Deezer's platform in the Middle East and North Africa regions.
  • Voluntis completes €30.1 million IPO on regulated market of Euronext in ParisJones Day advised Voluntis S.A., a French company specializing in therapeutic software, and Bryan, Garnier & Co and Oddo BHF SCA, joint lead managers and joint bookrunners, in connection with Voluntis' €30.1 million (US$34.9 million) initial public offering on the regulated market of Euronext in Paris.
  • ANSYS acquires OPTISJones Day advised ANSYS, Inc., the global leader and innovator of engineering simulation software, on its acquisition of OPTIS, a premier provider of software for scientific simulation of light, human vision, and physics-based visualization.
    •

    *Before sending, please note:

    *Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.